BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 32998374)

  • 1. Computational and In Vitro Investigation of (-)-Epicatechin and Proanthocyanidin B2 as Inhibitors of Human Matrix Metalloproteinase 1.
    Lee KE; Bharadwaj S; Yadava U; Kang SG
    Biomolecules; 2020 Sep; 10(10):. PubMed ID: 32998374
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural insights into the binding mode of flavonols with the active site of matrix metalloproteinase-9 through molecular docking and molecular dynamic simulations studies.
    Pradiba D; Aarthy M; Shunmugapriya V; Singh SK; Vasanthi M
    J Biomol Struct Dyn; 2018 Nov; 36(14):3718-3739. PubMed ID: 29068268
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Understanding the binding of inhibitors of matrix metalloproteinases by molecular docking, quantum mechanical calculations, molecular dynamics simulations, and a MMGBSA/MMBappl study.
    Singh T; Adekoya OA; Jayaram B
    Mol Biosyst; 2015 Apr; 11(4):1041-51. PubMed ID: 25611160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of novel selective MMP-9 inhibitors as potential anti-metastatic lead using structure-based hierarchical virtual screening and molecular dynamics simulation.
    Kalva S; Agrawal N; Skelton AA; Saleena LM
    Mol Biosyst; 2016 Jul; 12(8):2519-31. PubMed ID: 27250644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular insights in repurposing selective COX-2 inhibitor celecoxib against matrix metalloproteinases in potentiating delayed wound healing: a molecular docking and MMPB/SA based analysis of molecular dynamic simulations.
    Mude L; Jupudi S; Swaroop AK; Tallapaneni V; Karri VVSR
    J Biomol Struct Dyn; 2024 Mar; 42(5):2437-2448. PubMed ID: 37160705
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Shunmuga Priya V; Pradiba D; Aarthy M; Singh SK; Achary A; Vasanthi M
    J Biomol Struct Dyn; 2021 Nov; 39(18):7274-7293. PubMed ID: 32873178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Scaffold-based Screening and Molecular Dynamics Simulation Study to Identify Two Structurally Related Phenolic Compounds as Potent MMP1 Inhibitors.
    Patra S; Saravanan P; Das B; Subramanian V; Patra S
    Comb Chem High Throughput Screen; 2020; 23(8):757-774. PubMed ID: 32342802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extract from Rumex acetosa L. for prophylaxis of periodontitis: inhibition of bacterial in vitro adhesion and of gingipains of Porphyromonas gingivalis by epicatechin-3-O-(4β→8)-epicatechin-3-O-gallate (procyanidin-B2-Di-gallate).
    Schmuch J; Beckert S; Brandt S; Löhr G; Hermann F; Schmidt TJ; Beikler T; Hensel A
    PLoS One; 2015; 10(3):e0120130. PubMed ID: 25803708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An integrated computational and experimental approach to gaining selectivity for MMP-2 within the gelatinase subfamily.
    Fabre B; Filipiak K; Díaz N; Zapico JM; Suárez D; Ramos A; de Pascual-Teresa B
    Chembiochem; 2014 Feb; 15(3):399-412. PubMed ID: 24449516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple receptor-ligand based pharmacophore modeling and molecular docking to screen the selective inhibitors of matrix metalloproteinase-9 from natural products.
    Gao Q; Wang Y; Hou J; Yao Q; Zhang J
    J Comput Aided Mol Des; 2017 Jul; 31(7):625-641. PubMed ID: 28623487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of hydrophobic and hydrogen bonding interactions on the potency of ß-alanine analogs of G-protein coupled glucagon receptor inhibitors.
    Venugopal PP; Das BK; Soorya E; Chakraborty D
    Proteins; 2020 Feb; 88(2):327-344. PubMed ID: 31443129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mapping intermolecular interactions and active site conformations: from human MMP-1 crystal structure to molecular dynamics free energy calculations.
    Nash A; Birch HL; de Leeuw NH
    J Biomol Struct Dyn; 2017 Feb; 35(3):564-573. PubMed ID: 26886688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemically modified tetracyclines as inhibitors of MMP-2 matrix metalloproteinase: a molecular and structural study.
    Marcial BL; Sousa SF; Barbosa IL; Dos Santos HF; Ramos MJ
    J Phys Chem B; 2012 Nov; 116(46):13644-54. PubMed ID: 23121406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of selective MMP-9 inhibitors through multiple e-pharmacophore, ligand-based pharmacophore, molecular docking, and density functional theory approaches.
    Jana S; Singh SK
    J Biomol Struct Dyn; 2019 Mar; 37(4):944-965. PubMed ID: 29475408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of novel PI3Kδ inhibitors by docking, ADMET prediction and molecular dynamics simulations.
    Liu YY; Feng XY; Jia WQ; Jing Z; Xu WR; Cheng XC
    Comput Biol Chem; 2019 Feb; 78():190-204. PubMed ID: 30557817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening for the selective inhibitors of MMP-9 from natural products based on pharmacophore modeling and molecular docking in combination with bioassay experiment, hybrid QM/MM calculation, and MD simulation.
    Hou J; Zou Q; Wang Y; Gao Q; Yao W; Yao Q; Zhang J
    J Biomol Struct Dyn; 2019 Aug; 37(12):3135-3149. PubMed ID: 30079817
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The influence of flavonoid compounds on the in vitro inhibition study of a human fibroblast collagenase catalytic domain expressed in E. coli.
    Nguyen TT; Moon YH; Ryu YB; Kim YM; Nam SH; Kim MS; Kimura A; Kim D
    Enzyme Microb Technol; 2013 Jan; 52(1):26-31. PubMed ID: 23199735
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Matrix metalloproteinase inhibition by green tea catechins.
    Demeule M; Brossard M; Pagé M; Gingras D; Béliveau R
    Biochim Biophys Acta; 2000 Mar; 1478(1):51-60. PubMed ID: 10719174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The inhibition of collagenase induced degradation of collagen by the galloyl-containing polyphenols tannic acid, epigallocatechin gallate and epicatechin gallate.
    Jackson JK; Zhao J; Wong W; Burt HM
    J Mater Sci Mater Med; 2010 May; 21(5):1435-43. PubMed ID: 20162329
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of High Affinity and High Specificity Inhibitors of Matrix Metalloproteinase 14 through Computational Design and Directed Evolution.
    Arkadash V; Yosef G; Shirian J; Cohen I; Horev Y; Grossman M; Sagi I; Radisky ES; Shifman JM; Papo N
    J Biol Chem; 2017 Feb; 292(8):3481-3495. PubMed ID: 28087697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.